ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Laura Buffa - , Experimental Center of the Faculty of Medicine (Author)
  • Evelyn Fuchs - , University of Liverpool (UOL) (Author)
  • Massimo Pietropaolo - , University of Michigan, Ann Arbor (Author)
  • Francis Barr - , University of Liverpool (UOL) (Author)
  • Michele Solimena - , Experimental Center of the Faculty of Medicine, Department of Internal Medicine III, Max Planck Institute of Molecular Cell Biology and Genetics (Author)

Abstract

Islet cell autoantigen of 69 kDa (ICA69) is a small GTPase-binding protein of unknown function. ICA69 is enriched in the Golgi complex and its N-terminal half contains a BAR domain, a module that can bind/bend membranes and interacts with phospholipids. Here we show that in insulinoma INS-1 cells ICA69 binds to the small GTPase Rab2, which regulates the transport of COPI vesicles between the endoplasmic reticulum and the Golgi complex. Rab2 binds to ICA69 in a GTP-dependent fashion and recruits it to membranes. Over-expression of either Rab2 or ICA69 in INS-1 cells results in a phenotype characterized by: (i) impaired anterograde transport of the secretory granule protein precursors pro-ICA512 and chromogranin A; (ii) reduction of stimulated insulin secretion. Taken together, these data identify ICA69 as a novel Rab2 effector and point to its role in regulating the early transport of insulin secretory granule proteins.

Details

Original languageEnglish
Pages (from-to)197-209
Number of pages13
JournalEuropean journal of cell biology
Volume87
Issue number4
Publication statusPublished - 18 Apr 2008
Peer-reviewedYes

External IDs

PubMed 18187231

Keywords

Sustainable Development Goals

Keywords

  • β-COP, Diabetes T1D, ER, Golgi, ICA69, Intermediate compartment, Rab2, Trafficking